BenzingaTue, 07 Apr 2026 15:56:22 GMTCorbus Offers Upside Despite Post-FDA Update, Analyst Highlights Competitive EdgeCRBP+0.83%
Zacks Investment ResearchWed, 11 Mar 2026 14:55:28 GMTHow Much Upside is Left in Corbus Pharmaceuticals (CRBP)? Wall Street Analysts Think 318.33%CRBP+0.83%